David has over 35 years of diversified management experience, which includes managing global profit/loss at Johnson & Johnson and while at Warner-Lambert turning around troubled business operations, and negotiated a Joint Venture R&D Agreement with a major Japanese trading company. As the VP of Sales & Marketing at Somanetics Corp., he successfully launched the first Cerebral Oximeter in the global market. David has helped raise over $35 M in private (angel), venture (VC) and public (IPO) capital for various companies.

Most recently David was the CEO of Blaze Medical Devices, LLC., an early stage medical device company that develops technologies that enable integrated and standardized assessments of blood damage. Blaze offered the first device that tests the mechanical fragility of red blood cells to improve the quality control of donated blood while it is in storage. David moved Blaze from ideation to proof of concept and finally to a working prototype. He then secured intellectual property with 4 patents and funding with 2 NIH Grants and $1.3 M in angel funding in a billion-dollar underserved market. David  served as an Executive-in-Residence (standby CEO) at the Pittsburgh Life Science Greenhouse, an investment firm that provides resources and tools for emerging life science companies. There he was responsible for global recruiting, mentoring, and assisting with business plan analysis and preparation. He also helped strategize investor presentations, connected entrepreneurs with institutional and angel investors, reviewed potential investments, and make funding recommendations 

David served as a Board Member for the Detroit chapter of Association for Corporate Growth and is still active in their M&A activities. He is a Founder/Chairman of Great Lakes Angels, the first angel group in Michigan, founding member for the MIT Enterprise Forum of the Great Lakes, founding member of Michigan Venture Capital Association, and Charter Member of the Angel Capital Association.